Vildagliptin / Metformin hydrochloride Accord Европейски съюз - български - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - Захарен диабет тип 2 - Лекарства, използвани при диабет - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).

Opfolda Европейски съюз - български - EMA (European Medicines Agency)

opfolda

amicus therapeutics europe limited - миглустат - Гликогенна складова болест тип ii - Други продукти на храносмилателния тракт и метаболизма - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Европейски съюз - български - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, метформин хидрохлорид - Захарен диабет тип 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).

Braunol 7,5 g/100 g cutaneous solution България - български - Изпълнителна агенция по лекарствата

braunol 7,5 g/100 g cutaneous solution

b.braun melsungen ag - Повидон-йод - 7,5 g/100 g cutaneous solution

Braunovidon 10% oinment България - български - Изпълнителна агенция по лекарствата

braunovidon 10% oinment

b.braun melsungen ag; - Повидон-йод - 10% oinment

Natrium Chloride 0,9 % + Glucose 5 % B. Braun solution for infusion  България - български - Изпълнителна агенция по лекарствата

natrium chloride 0,9 % + glucose 5 % b. braun solution for infusion 

b.braun melsungen ag - Електролити с въглехидрати - 0,9 % + glucose 5 % b. braun solution for infusion 

Xiliarx Европейски съюз - български - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - вилдаглиптин - Захарен диабет тип 2 - Лекарства, използвани при диабет - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).

Galvus Европейски съюз - български - EMA (European Medicines Agency)

galvus

novartis europharm limited - вилдаглиптин - Захарен диабет тип 2 - Лекарства, използвани при диабет - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Европейски съюз - български - EMA (European Medicines Agency)

jalra

novartis europharm limited - вилдаглиптин - Захарен диабет тип 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).

Levofloxacin B. Braun  5 mg/ml solution for infusion България - български - Изпълнителна агенция по лекарствата

levofloxacin b. braun  5 mg/ml solution for infusion

b.braun melsungen ag - Левофлоксацин - 5 mg/ml solution for infusion